The Impact of Differential Expression of Extracellular Matrix Metalloproteinase Inducer, Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and PDGF-AA on the Chronicity of Venous Leg Ulcers
- 31 March 2006
- journal article
- Published by Elsevier BV in European Journal of Vascular and Endovascular Surgery
- Vol. 31 (3), 306-310
- https://doi.org/10.1016/j.ejvs.2005.08.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cellular, Biochemical, and Clinical Aspects of Wound HealingSurgical Infections, 2002
- Wound Fluids from Human Pressure Ulcers Contain Elevated Matrix Metalloproteinase Levels and Activity Compared to Surgical Wound FluidsJournal of Investigative Dermatology, 1996
- Human Keratinocytes Express EMMPRIN, an Extracellular Matrix Metalloproteinase InducerJournal of Investigative Dermatology, 1996
- Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.JCI Insight, 1995
- Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9Journal of Investigative Dermatology, 1993
- The "trap" hypothesis of venous ulcerationThe Lancet, 1993
- Differential expression of platelet-derived growth factor α- and β-receptors on fat-storing cells and endothelial cells of rat liverExperimental Cell Research, 1991
- Causes of venous ulceration: a new hypothesisBMJ, 1988
- Effects of bone associated growth factors on dna, collagen and osteocalcin synthesis in cultured fetal rat calvariaeBone, 1988
- Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration.BMJ, 1982